Lonza Group, CH0013841017

Lonza stock holds firm as Swiss trading data points higher

Published on 08/17/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza stock is steady in Swiss trading, with the latest quote at CHF 562.60 and a 1.78 percent daily move. The most recent market snapshot also shows a 6.42 percent year-to-date gain.

Börsen-Editorial: Dunkler Monitor mit BIOTECH, CDMO und SIX SWISS Beschriftung und Kursdiagrammen
Lonza CH0013841017 Boersen Bildschirm BIOTECH CDMO SIX SWISS neutrale Charts Editorial Stil, Illustration mit AI erstellt.

Lonza Group AG (CH0013841017) traded at CHF 562.60 in the latest Swiss market snapshot, with the quote down 1.78 percent on the day and up 6.42 percent year to date. The same snapshot also shows Lonza at CHF 561.40 with a 2.16 percent daily loss in another market view, underscoring how the shares have been moving inside a tight range.

Swiss market readout

The share price levels in the available quote pages point to a stock that has held above CHF 560 even after a softer session. For a large Swiss healthcare supplier, that leaves the market focused on whether the current level can hold above recent trading marks rather than on a single intraday print.

One detail stands out: the year-to-date gain of 6.42 percent is still intact in the most detailed market snapshot, even with the daily decline. That combination matters because it gives investors a simple comparison between the longer trend and the latest session.

Latest company backdrop

Lonza's most recent reporting context in the search set points to the company's latest interim operating picture rather than a new release today. In the absence of a fresh company filing in the returned sources, the best available context is the market data itself and the current Swiss trading tone.

That makes the price action the main evidence for now. The stock is still trading as a Swiss blue-chip industrial health-care name, and the available quote data keeps the conversation anchored to the most recent session rather than to older fundamentals.

Product focus

Lonza's work spans contract development and manufacturing services for biopharma clients, with a business model built around complex drug substance and drug product production. That mix is the operating backdrop behind the share-price reaction because investors usually watch how stable that demand appears in each reporting cycle.

Price and listing

Lonza stock last traded at CHF 562.60 in the cited Swiss quote view. As a second market reference, another snapshot showed CHF 561.40, keeping the shares clustered in the same band on August 17, 2026.

Fact box

Company: Lonza Group AG
ISIN: CH0013841017
Ticker: LONN
Exchange: SIX Swiss Exchange
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: SMI

Disclaimer...

en | CH0013841017 | LONZA GROUP | boerse | 69956838 | bgmi